• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of September 13, 2023

    FDA

    Enforcement Report - Week of February 22, 2023

    FDA

    Shandong`s Generic Milrinone Lactate Receives Approval in the U.S.

    FDA

    Hyloris Expands Cardiovascular Pipeline with Breakthrough Extended-Release

    GLOBENEWSWIRE

    Caplin`s Generic Milrinone Lactate Receives Approval in US

    FDA

    Aurobindo Pharma`s Generic MILRINONE LACTATE Receives Approval In The US

    FDA

    Aurobindo Pharma`s Generic Milrinone Lactate Receives Approval in US

    FDA

    Gland Pharma`s Generic Milrinone Lactate Receives Approval in US

    FDA

    Nanjing King-Friend`s Generic Milrinone Lactate Receives Approval in US

    FDA

    Nanjing King-Friend`s Generic Milrinone Lactate Receives Approval in US

    FDA

    Enforcement Report - Week of July 24, 2019

    FDA

    Enforcement Report - Week of May 24, 2017

    FDA

    US FDA Enforcement Report- 8/June/2016

    FDA

    Walgreens Infusion Services, Ongoing Class II recall of Milrinone various strengths in dextrose because of Lack of sterility assurance.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.